Be a part of 13^th International Conference on Eye and Ophthalmology

1. Artificial Intelligence & Machine Learning in Ophthalmology:
AI is revolutionizing ophthalmology with automated diagnostics, predictive analytics, and real-time decision-making. This track explores how AI enhances imaging interpretation, improves disease prediction, and supports clinical workflows while addressing ethical challenges.
Sub-tracks: Deep learning in retinal imaging | AI for glaucoma & DR screening | Predictive analytics in surgical outcomes | Ethical AI in ophthalmology

2. Oculomics & Systemic Health:
The emerging field of oculomics uses retinal imaging as a window into overall health. This track highlights cutting-edge studies linking eye biomarkers to cardiovascular, neurological, and metabolic diseases, enabling non-invasive screening and risk assessment.
Sub-tracks: Retinal biomarkers for systemic disease | Oculomics in neurodegeneration | AI-enhanced systemic diagnostics | Future of whole-body health through the eye

3. Tele-Ophthalmology & Digital Health:
Teleophthalmology has become a cornerstone of accessible eye care. This session explores mobile health apps, cloud-based diagnostics, and virtual clinics that bridge healthcare gaps. Emphasis is on sustainable models and patient-centered digital care.
Sub-tracks: Mobile eye imaging | Virtual consultations & triaging | AI integration in teleophthalmology | Access equity in underserved regions

4. Advances in Cataract and Refractive Surgery:
Cataract and refractive surgery continue to evolve with precision technologies. This track examines new IOL designs, femtosecond laser-assisted procedures, and surgical pearls that improve outcomes and patient satisfaction.
Sub-tracks: Premium & accommodative IOLs | Femtosecond-assisted cataract surgery | Innovations in LASIK/SMILE | Managing complex cataract cases

5. Glaucoma: Innovations in Diagnosis and Management:
Glaucoma management is rapidly advancing with AI diagnostics, slow-release drug delivery, and minimally invasive glaucoma surgery (MIGS). This track highlights breakthroughs in early detection, surgical innovation, and lifelong management strategies.
Sub-tracks: AI in glaucoma detection | MIGS vs traditional surgery | Sustained-release therapeutics | Imaging innovations in glaucoma

6. Retina and Vitreous Disorders:
This track addresses advances in the diagnosis and treatment of retinal diseases, including diabetic retinopathy, AMD, and retinal vein occlusions. Focus is on gene therapy, cellular therapies, and next-gen imaging technologies.
Sub-tracks: Imaging innovations in retina | Gene & cell therapy in retinal diseases | Diabetic retinopathy management | Advances in vitreoretinal surgery

7. Cornea, External Diseases, and Ocular Surface Innovations:
From corneal transplantation to ocular surface disease management, this track covers regenerative solutions and surgical innovations. Dry eye therapies and bioengineered corneas are key highlights.
Sub-tracks: Regenerative medicine in cornea | Corneal transplantation updates | Keratoprosthesis & artificial corneas | Advances in dry eye therapies

8. Pediatric Ophthalmology & Myopia Control:
Childhood vision disorders and the global myopia epidemic are growing challenges. This track discusses prevention, pharmacologic interventions, and lifestyle approaches for controlling progressive myopia and improving pediatric eye health.
Sub-tracks: Pediatric cataracts & strabismus | Lifestyle & digital strain management | Pharmacologic myopia control | School-based vision screening programs

9. Neuro-Ophthalmology: Vision and the Brain:
Neuro-ophthalmology bridges the eye and the brain. This session highlights acute visual syndromes, optic neuropathies, and advanced imaging that supports rapid diagnosis and management of neuro-ophthalmic emergencies.
Sub-tracks: Optic neuritis & demyelination | Cranial nerve palsy & visual syndromes | Neuroimaging for diagnosis | Advances in electrophysiology

10. Ocular Oncology and Pathology:
This track explores precision diagnostics and therapies for ocular tumors. Sessions cover molecular pathology, advanced imaging, and patient-tailored treatments for intraocular and ocular surface tumors.
Sub-tracks: Ocular surface tumors | Retinoblastoma management | Uveal melanoma advances | Imaging & pathology integration

11. Genetics & Precision Ophthalmology:
Genomic breakthroughs are paving the way for precision ophthalmology. This track focuses on genetic testing, CRISPR applications, and personalized therapies for inherited retinal and corneal diseases.
Sub-tracks: Genetic testing in ophthalmology | CRISPR gene-editing applications | Inherited retinal dystrophies | Personalized treatment models

12. Innovations in Surgical Ophthalmology:
Emerging surgical technologies—from robotics to AR/VR—are transforming ophthalmic practice. This track highlights advanced visualization systems, surgical training, and robotic-assisted procedures.
Sub-tracks: Robotic ophthalmic surgery | 3D visualization platforms | AR/VR in surgical training | Microsurgical precision tools

13. Global Eye Health & Preventive Ophthalmology:
This track emphasizes strategies to reduce preventable blindness and promote eye health worldwide. It covers community outreach, policy frameworks, and global initiatives that improve access to vision care.
Sub-tracks: Blindness prevention programs | Public health ophthalmology | Policy and advocacy | Community-based outreach models

14. Sustainability in Ophthalmology:
Eco-conscious practices are gaining importance in healthcare. This track discusses green operating rooms, sustainable device manufacturing, and environmentally friendly practices in ophthalmology.
Sub-tracks: Sustainable surgery practices | Reducing clinical carbon footprints | Eco-friendly medical devices | Global frameworks for green eye care

15. Young Ophthalmologists & Future Leaders Forum:
Dedicated to early-career professionals, this track features research showcases, mentorship opportunities, and innovation challenges. It fosters leadership development and collaboration among the next generation of ophthalmologists.
Sub-tracks: Young researcher presentations | Mentorship & career growth | Case-based learning | Innovation & startup pitches

The global ophthalmology market is witnessing steady expansion, fueled by rising eye disease prevalence, technological breakthroughs, and increasing access to specialized care. Recent studies project the market for ophthalmic devices, diagnostics, and therapeutics to exceed USD 80 billion by 2026, growing at a CAGR of about 6–7%.

Globally, more than 2.2 billion people suffer from vision impairment or blindness, with cataract, glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD) being the primary causes. The growing aging population—expected to reach one in six people over age 60 by 2030—continues to drive demand for cataract and refractive surgeries. At the same time, the global rise in myopia, especially across Asia-Pacific, has created urgent needs for prevention, early intervention, and innovative treatment strategies.

Technological innovation is reshaping ophthalmology, with artificial intelligence, tele-ophthalmology, robot-assisted surgery, and genetic therapies transforming the way eye diseases are diagnosed and treated. Investments from pharmaceutical companies and device manufacturers are accelerating the development of next-generation solutions.

Regionally, North America and Europe dominate in terms of revenue, while Asia-Pacific represents the fastest-growing market due to high myopia rates, large patient populations, and rapid adoption of digital health solutions. Emerging markets in Africa and Latin America also present significant opportunities for preventive ophthalmology and outreach programs.

The outlook for ophthalmology is clear: innovation, accessibility, and compassionate care will remain the foundation for growth in the years ahead.